Home › Funds › DGS Capital Management, LLC › GSK
DGS Capital Management, LLC position in GSK
GSK PLC ADR F · Health Care
DGS Capital Management, LLC reported holding 42,695 shares of GSK (GSK PLC ADR F) in its Q1 2026 13F filing — a position valued at US$2.4M, representing 0.41% of its reported portfolio and ranking #40 among its reported holdings. DGS Capital Management, LLC has disclosed GSK holdings in 10 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How DGS Capital Management, LLC's GSK position evolved
DGS Capital Management, LLC first disclosed a stake in GSK in Q3 2023 at 37,463 shares (US$1.4M). The position peaked in Q1 2026 at 42,695 shares, worth US$2.4M. Across 10 filings, DGS Capital Management, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 42,695 shares valued at US$2.4M — an increase of 2,761 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 37.46K | $1.36M | New |
| Q4 2023 | 30.23K | $1.12M | Reduce |
| Q1 2024 | 30.69K | $1.32M | Add |
| Q3 2024 | 34.44K | $1.41M | Add |
| Q4 2024 | 28.27K | $956.02K | Reduce |
| Q1 2025 | 29.13K | $1.13M | Add |
| Q2 2025 | 32.56K | $1.25M | Add |
| Q3 2025 | 36.34K | $1.57M | Add |
| Q4 2025 | 39.93K | $1.96M | Add |
| Q1 2026 | 42.70K | $2.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on DGS Capital Management, LLC
FAQ
How long has DGS Capital Management, LLC held GSK?
DGS Capital Management, LLC has disclosed GSK holdings in 10 of the last 11 reported quarters, going back to Q3 2023.
What is DGS Capital Management, LLC's current position in GSK?
As of Q1 2026, DGS Capital Management, LLC holds 42.70K shares of GSK (GSK PLC ADR F), valued at $2.36M, representing 0.41% of its reported portfolio and ranking #40.
Has DGS Capital Management, LLC been buying or selling GSK?
In the latest 13F filing (Q1 2026), DGS Capital Management, LLC increased its position in GSK. The position peaked in Q1 2026 at 42.70K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.